Announcements Trials
Browse Landscape

Phase

Phase 3 18Phase 2 14Phase 4 2Phase 2/3 2Phase 1 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Flutamide × Clear all
NCT00054106 2023-08-04

Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

Canadian Cancer Trials Group

Phase 1 Completed
25 enrolled
Genitourinary

Prostatic Neoplasms

NCT00026377 2013-09-05

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

University of Chicago

Phase 1 Completed
3 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡